Bausch Health Companies (BHC) Cash from Operations (2009 - 2026)
Bausch Health Companies (BHC) posted Cash from Operations of 670000000.0 for Q2 2026, up 191.3% sequentially from 230000000.0 in Q1 2026, and up 131.83% YoY from 289000000.0 in Q2 2025.
Bausch Health Companies (BHC) Cash from Operations (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Cash from Operations for 18 years, with the latest figure at 670000000.0 in Q2 2026.
- Quarterly Cash from Operations rose 131.83% year-over-year to 670000000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 1800000000.0 (up 19.52% YoY) and the FY2025 annual result came in at 1400000000.0, down 12.34% from the prior year.
- Cash from Operations improved to 670000000.0 in Q2 2026 per BHC's latest filing, from 230000000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 670000000.0 in Q2 2026 and troughed at 1263000000.0 in Q3 2022.
- A 5-year average of 233388888.89 and a median of 285500000.0 in 2023 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 1879.17% in 2022, down 323.94% in 2022.
- Over 5 years, Cash from Operations stood at 475000000.0 in 2022, then declined by 17.89% to 390000000.0 in 2023, then jumped by 54.1% to 601000000.0 in 2024, then retreated by 17.64% to 495000000.0 in 2025, then soared by 35.35% to 670000000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 670000000.0, 230000000.0, and 495000000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 730.75 Mn | 2.10 Bn | 670.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 670.00 Mn |
| Jun 30, 2026 | 670.00 Mn |
| Mar 31, 2026 | 230.00 Mn |
| Mar 31, 2026 | 230.00 Mn |
| Dec 31, 2025 | 495.00 Mn |
| Dec 31, 2025 | 495.00 Mn |
| Sep 30, 2025 | 405.00 Mn |
| Sep 30, 2025 | 405.00 Mn |
| Jun 30, 2025 | 289.00 Mn |
| Jun 30, 2025 | 289.00 Mn |
| Mar 31, 2025 | 211.00 Mn |
| Mar 31, 2025 | 211.00 Mn |
| Dec 31, 2024 | 601.00 Mn |
| Dec 31, 2024 | 601.00 Mn |
| Sep 30, 2024 | 405.00 Mn |
| Sep 30, 2024 | 405.00 Mn |
| Jun 30, 2024 | 380.00 Mn |
| Jun 30, 2024 | 380.00 Mn |
| Mar 31, 2024 | 211.00 Mn |
| Mar 31, 2024 | 211.00 Mn |